Litcius/Paper detail

Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy

Clodagh P. O’Neill, Róisín M. Dwyer

2020Cells88 citationsDOIOpen Access PDF

Abstract

Improved understanding of microRNA expression and function in cancer has revealed a range of microRNAs that negatively regulate many oncogenic pathways, thus representing potent tumor suppressors. Therapeutic targeting of the expression of these microRNAs to the site of tumors and metastases provides a promising avenue for cancer therapy. To overcome challenges associated with microRNA degradation, transient expression and poor targeting, novel nanoparticles are being developed and employed to shield microRNAs for tumor-targeted delivery. This review focuses on studies describing a variety of both natural and synthetic nanoparticle delivery vehicles that have been engineered for tumor-targeted delivery of tumor suppressor microRNAs in vivo.

Topics & Concepts

microRNASuppressorCancerCancer researchIn vivoCancer therapyMedicineBiologyGeneInternal medicineBiotechnologyBiochemistryMicroRNA in disease regulationRNA Interference and Gene DeliveryExtracellular vesicles in disease
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy | Litcius